Progress with new Alzheimer’s drug lecanemab announced by manufacturers Eisai and Biogen
Progress with new Alzheimer’s drug lecanemab announced by manufacturers Eisai and Biogen .Yesterday (27 September 2022), Eisai Co. Ltd. and Biogen announced top-line results for a major trial on the drug lecanemab in slowing down the progress of Alzheimer’s disease. Alzheimer's Society comments on this Alzheimer’s progression drug hope.